{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:10:01Z","timestamp":1793211001646,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA143907"],"award-info":[{"award-number":["U54CA143907"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12951-016-0185-x","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T23:24:39Z","timestamp":1461281079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Lee B.","family":"Sims","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis T.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann B.","family":"Frieboes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Steinbach-Rankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"185_CR1","unstructured":"ACS. Learn About Cancer\u2014Cervical Cancer\u2014Detailed Guide\u2014What are the key statistics about cervical cancer? American Cancer Society. 2016. http:\/\/www.cancer.org\/cancer\/cervicalcancer\/detailedguide\/cervical-cancer-key-statistics ."},{"issue":"4","key":"185_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212\u201336. doi: 10.3322\/caac.20121 .","journal-title":"CA Cancer J Clin"},{"key":"185_CR3","unstructured":"CDC. Gynecologic cancers. Center for Disease Control (CDC). 2015. http:\/\/www.cdc.gov\/cancer\/cervical\/ ."},{"key":"185_CR4","unstructured":"NCI. NCI: HPV and cancer. National Cancer Institute. 2015. http:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-fact-sheet ."},{"key":"185_CR5","doi-asserted-by":"publisher","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","volume":"30","author":"JT Schiller","year":"2012","unstructured":"Schiller JT, Castellsague X, Garland SM. A review of clinical trials of Human papillomavirus prophylactic vaccines. Vaccine. 2012;30:F123\u201338. doi: 10.1016\/j.vaccine.2012.04.108 .","journal-title":"Vaccine"},{"issue":"7","key":"185_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jama.298.7.743","volume":"298","author":"A Hildesheim","year":"2007","unstructured":"Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, et al. Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection\u2014a randomized trial. JAMA. 2007;298(7):743\u201353. doi: 10.1001\/jama.298.7.743 .","journal-title":"JAMA"},{"key":"185_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/rmv.1825","volume":"25","author":"JZ Chen","year":"2015","unstructured":"Chen JZ, Gu WY, Yang L, Chen C, Shao RF, Xu KW, et al. Nanotechnology in the management of cervical cancer. Rev Med Virol. 2015;25:72\u201383. doi: 10.1002\/rmv.1825 .","journal-title":"Rev Med Virol"},{"issue":"1","key":"185_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cncr.11877","volume":"100","author":"PT Jensen","year":"2004","unstructured":"Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer. 2004;100(1):97\u2013106. doi: 10.1002\/cncr.11877 .","journal-title":"Cancer"},{"issue":"9509","key":"185_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","volume":"367","author":"M Kyrgiou","year":"2006","unstructured":"Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367(9509):489\u201398. doi: 10.1016\/S0140-6736(06)68181-6 .","journal-title":"Lancet"},{"issue":"7","key":"185_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/adhm.201300519","volume":"3","author":"M Yang","year":"2014","unstructured":"Yang M, Yu T, Wang YY, Lai SK, Zeng Q, Miao BL, et al. Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth. Adv Healthc Mat. 2014;3(7):1044\u201352. doi: 10.1002\/adhm.201300519 .","journal-title":"Adv Healthc Mat"},{"key":"185_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","volume":"66","author":"N Bertrand","year":"2014","unstructured":"Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2\u201325. doi: 10.1016\/j.addr.2013.11.009 .","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"185_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505\u201322. doi: 10.1016\/j.jconrel.2012.01.043 .","journal-title":"J Control Release"},{"issue":"1\u20132","key":"185_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","volume":"70","author":"KS Soppimath","year":"2001","unstructured":"Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1\u20132):1\u201320.","journal-title":"J Control Release"},{"key":"185_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2014.05.036","volume":"187","author":"CM Dawidczyk","year":"2014","unstructured":"Dawidczyk CM, Kim C, Park JH, Russell LM, Lee KH, Pomper MG, et al. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J Control Release. 2014;187:133\u201344. doi: 10.1016\/j.jconrel.2014.05.036 .","journal-title":"J Control Release"},{"key":"185_CR15","doi-asserted-by":"publisher","first-page":"374252","DOI":"10.1155\/2013\/374252","volume":"2013","author":"S Salmaso","year":"2013","unstructured":"Salmaso S, Caliceti P. Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv. 2013;2013:374252. doi: 10.1155\/2013\/374252 .","journal-title":"J Drug Deliv"},{"issue":"2","key":"185_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/wnan.1157","volume":"4","author":"Z Amoozgar","year":"2012","unstructured":"Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4(2):219\u201333. doi: 10.1002\/wnan.1157 .","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"185_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-407173-5.00002-9","volume":"118","author":"AA Alexander-Bryant","year":"2013","unstructured":"Alexander-Bryant AA, Vanden Berg-Foels WS, Wen X. Bioengineering strategies for designing targeted cancer therapies. Adv Cancer Res. 2013;118:1\u201359. doi: 10.1016\/B978-0-12-407173-5.00002-9 .","journal-title":"Adv Cancer Res"},{"issue":"11","key":"185_CR18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/ph5111177","volume":"5","author":"A Erazo-Oliveras","year":"2012","unstructured":"Erazo-Oliveras A, Muthukrishnan N, Baker R, Wang TY, Pellois JP. Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals (Basel). 2012;5(11):1177\u2013209. doi: 10.3390\/ph5111177 .","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"185_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molmed.2012.04.012","volume":"18","author":"E Koren","year":"2012","unstructured":"Koren E, Torchilin VP. Cell-penetrating peptides: breaking through to the other side. Trends Mol Med. 2012;18(7):385\u201393. doi: 10.1016\/j.molmed.2012.04.012 .","journal-title":"Trends Mol Med"},{"issue":"7","key":"185_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1517\/17425247.2012.689285","volume":"9","author":"T Lehto","year":"2012","unstructured":"Lehto T, Kurrikoff K, Langel U. Cell-penetrating peptides for the delivery of nucleic acids. Expert Opin Drug Deliv. 2012;9(7):823\u201336. doi: 10.1517\/17425247.2012.689285 .","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"185_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/mt.2011.284","volume":"20","author":"H Margus","year":"2012","unstructured":"Margus H, Padari K, Pooga M. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther. 2012;20(3):525\u201333. doi: 10.1038\/mt.2011.284 .","journal-title":"Mol Ther"},{"issue":"2\u20133","key":"185_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.addr.2007.03.004","volume":"59","author":"BR Meade","year":"2007","unstructured":"Meade BR, Dowdy SF. Exogenous siRNA delivery using peptide transduction domains\/cell penetrating peptides. Adv Drug Deliv Rev. 2007;59(2\u20133):134\u201340. doi: 10.1016\/j.addr.2007.03.004 .","journal-title":"Adv Drug Deliv Rev"},{"issue":"4\u20135","key":"185_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.addr.2007.10.004","volume":"60","author":"BR Meade","year":"2008","unstructured":"Meade BR, Dowdy SF. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev. 2008;60(4\u20135):530\u20136.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"185_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BC20070116","volume":"100","author":"MC Morris","year":"2008","unstructured":"Morris MC, Deshayes S, Heitz F, Divita G. Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol Cell. 2008;100(4):201\u201317. doi: 10.1042\/BC20070116 .","journal-title":"Biol Cell"},{"issue":"12","key":"185_CR25","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1002\/jcb.23313","volume":"112","author":"F Mussbach","year":"2011","unstructured":"Mussbach F, Franke M, Zoch A, Schaefer B, Reissmann S. Transduction of peptides and proteins into live cells by cell penetrating peptides. J Cell Biochem. 2011;112(12):3824\u201333. doi: 10.1002\/jcb.23313 .","journal-title":"J Cell Biochem"},{"issue":"1","key":"185_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20061100","volume":"399","author":"ST Henriques","year":"2006","unstructured":"Henriques ST, Melo MN, Castanho MA. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J. 2006;399(1):1\u20137. doi: 10.1042\/BJ20061100 .","journal-title":"Biochem J"},{"issue":"9","key":"185_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.molmed.2015.06.005","volume":"21","author":"D Raucher","year":"2015","unstructured":"Raucher D, Ryu JS. Cell-penetrating peptides: strategies for anticancer treatment. Trends Mol Med. 2015;21(9):560\u201370. doi: 10.1016\/j.molmed.2015.06.005 .","journal-title":"Trends Mol Med"},{"issue":"4","key":"185_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.addr.2004.10.007","volume":"57","author":"B Gupta","year":"2005","unstructured":"Gupta B, Levchenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev. 2005;57(4):637\u201351. doi: 10.1016\/j.addr.2004.10.007 .","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"185_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbrc.2013.01.096","volume":"432","author":"AA Mokhtarieh","year":"2013","unstructured":"Mokhtarieh AA, Kim S, Lee Y, Chung BH, Lee MK. Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs. Biochem Biophys Res Commun. 2013;432(2):359\u201364. doi: 10.1016\/j.bbrc.2013.01.096 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"185_CR30","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1093\/nar\/gkg385","volume":"31","author":"F Simeoni","year":"2003","unstructured":"Simeoni F, Morris MC, Heitz F, Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 2003;31(11):2717\u201324.","journal-title":"Nucleic Acids Res"},{"issue":"30","key":"185_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.actbio.2015.11.029","volume":"15","author":"JM Steinbach","year":"2016","unstructured":"Steinbach JM, Seo YE, Saltzman WM. Cell penetrating peptide-modified PLGA nanoparticles with enhanced cell internalization. Acta Biomater. 2016;15(30):49\u201361.","journal-title":"Acta Biomater"},{"issue":"8","key":"185_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6(8):583\u201392. doi: 10.1038\/nrc1893 .","journal-title":"Nat Rev Cancer"},{"key":"185_CR33","first-page":"113","volume":"46","author":"R Sutherland","year":"1971","unstructured":"Sutherland R, McCredie J, Inch W. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst. 1971;46:113\u201320.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"185_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2217\/nnm.15.195","volume":"11","author":"LT Curtis","year":"2016","unstructured":"Curtis LT, England CG, Wu M, Lowengrub J, Frieboes HB. An interdisciplinary computational\/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity. Nanomedicine (Lond). 2016;11(3):197\u2013216. doi: 10.2217\/nnm.15.195 .","journal-title":"Nanomedicine (Lond)"},{"issue":"12","key":"185_CR35","doi-asserted-by":"publisher","first-page":"e0144888","DOI":"10.1371\/journal.pone.0144888","volume":"10","author":"LT Curtis","year":"2015","unstructured":"Curtis LT, Wu M, Lowengrub J, Decuzzi P, Frieboes HB. Computational modeling of tumor response to drug release from vasculature-bound nanoparticles. PLoS ONE. 2015;10(12):e0144888. doi: 10.1371\/journal.pone.0144888 .","journal-title":"PLoS ONE"},{"issue":"2","key":"185_CR36","first-page":"265","volume":"2","author":"TT Goodman","year":"2007","unstructured":"Goodman TT, Olive PL, Pun SH. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomed. 2007;2(2):265\u201374.","journal-title":"Int J Nanomed"},{"issue":"5","key":"185_CR37","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1021\/nn301282m","volume":"6","author":"K Huang","year":"2012","unstructured":"Huang K, Ma H, Liu J, Huo S, Kumar A, Wei T, et al. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano. 2012;6(5):4483\u201393. doi: 10.1021\/nn301282m .","journal-title":"ACS Nano"},{"issue":"7","key":"185_CR38","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1166\/jbn.2015.2067","volume":"11","author":"M Neshatian","year":"2015","unstructured":"Neshatian M, Chung S, Yohan D, Yang C, Chithrani DB. Uptake of gold nanoparticles in breathless (hypoxic) cancer cells. J Biomed Nanotechnol. 2015;11(7):1162\u201372.","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"185_CR39","doi-asserted-by":"publisher","first-page":"e56876","DOI":"10.1371\/journal.pone.0056876","volume":"8","author":"HB Frieboes","year":"2013","unstructured":"Frieboes HB, Wu M, Lowengrub J, Decuzzi P, Cristini V. A computational model for predicting nanoparticle accumulation in tumor vasculature. PLoS ONE. 2013;8(2):e56876. doi: 10.1371\/journal.pone.0056876 .","journal-title":"PLoS ONE"},{"key":"185_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jtbi.2014.04.012","volume":"355","author":"M Wu","year":"2014","unstructured":"Wu M, Frieboes HB, Chaplain MA, McDougall SR, Cristini V, Lowengrub JS. The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems. J Theor Biol. 2014;355:194\u2013207. doi: 10.1016\/j.jtbi.2014.04.012 .","journal-title":"J Theor Biol"},{"key":"185_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.2147\/IJN.S23758","volume":"7","author":"M Li","year":"2012","unstructured":"Li M, Panagi Z, Avgoustakis K, Reineke J. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content. Int J Nanomed. 2012;7:1345\u201356. doi: 10.2147\/IJN.S23758 .","journal-title":"Int J Nanomed"},{"issue":"3","key":"185_CR42","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1208\/s12248-013-9478-2","volume":"15","author":"Y Gao","year":"2013","unstructured":"Gao Y, Li M, Chen B, Shen Z, Guo P, Wientjes MG, et al. Predictive models of diffusive nanoparticle transport in 3-dimensional tumor cell spheroids. The AAPS journal. 2013;15(3):816\u201331. doi: 10.1208\/s12248-013-9478-2 .","journal-title":"The AAPS journal."},{"issue":"3","key":"185_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","volume":"141","author":"P Decuzzi","year":"2010","unstructured":"Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release. 2010;141(3):320\u20137. doi: 10.1016\/j.jconrel.2009.10.014 .","journal-title":"J Control Release"},{"key":"185_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0065-2660(10)69009-8","volume":"69","author":"B Godin","year":"2010","unstructured":"Godin B, Driessen WH, Proneth B, Lee SY, Srinivasan S, Rumbaut R, et al. An integrated approach for the rational design of nanovectors for biomedical imaging and therapy. Adv Genet. 2010;69:31\u201364. doi: 10.1016\/S0065-2660(10)69009-8 .","journal-title":"Adv Genet"},{"key":"185_CR45","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2147\/IJN.S20283","volume":"6","author":"DP Boso","year":"2011","unstructured":"Boso DP, Lee SY, Ferrari M, Schrefler BA, Decuzzi P. Optimizing particle size for targeting diseased microvasculature: from experiments to artificial neural networks. Int J Nanomed. 2011;6:1517\u201326. doi: 10.2147\/IJN.S20283 .","journal-title":"Int J Nanomed"},{"issue":"30","key":"185_CR46","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1016\/j.biomaterials.2006.05.024","volume":"27","author":"P Decuzzi","year":"2006","unstructured":"Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials. 2006;27(30):5307\u201314. doi: 10.1016\/j.biomaterials.2006.05.024 .","journal-title":"Biomaterials"},{"issue":"1","key":"185_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11095-008-9697-x","volume":"26","author":"P Decuzzi","year":"2009","unstructured":"Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: does geometry really matter? Pharm Res. 2009;26(1):235\u201343. doi: 10.1007\/s11095-008-9697-x .","journal-title":"Pharm Res"},{"issue":"49","key":"185_CR48","doi-asserted-by":"publisher","first-page":"495101","DOI":"10.1088\/0957-4484\/20\/49\/495101","volume":"20","author":"SY Lee","year":"2009","unstructured":"Lee SY, Ferrari M, Decuzzi P. Shaping nano-\/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology. 2009;20(49):495101. doi: 10.1088\/0957-4484\/20\/49\/495101 .","journal-title":"Nanotechnology"},{"issue":"12","key":"185_CR49","doi-asserted-by":"publisher","first-page":"e0144888","DOI":"10.1371\/journal.pone.0144888","volume":"10","author":"LT Curtis","year":"2015","unstructured":"Curtis LT, Wu M, Lowengrub J, Decuzzi P, Frieboes HB. Computational modeling of tumor response to drug release from vasculature-bound nanoparticles. PLoS ONE. 2015;10(12):e0144888.","journal-title":"PLoS ONE."},{"issue":"1","key":"185_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijpharm.2011.04.067","volume":"423","author":"J Balzeau","year":"2012","unstructured":"Balzeau J, Peterson A, Eyer J. The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells. Int J Pharm. 2012;423(1):77\u201383. doi: 10.1016\/j.ijpharm.2011.04.067 .","journal-title":"Int J Pharm"},{"issue":"5","key":"185_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5582\/bst.2013.v7.5.209","volume":"7","author":"A Saini","year":"2013","unstructured":"Saini A, Jaswal RR, Negi R, Nandel FS. Insights on the structural characteristics of Vim-TBS (58-81) peptide for future applications as a cell penetrating peptide. Biosci Trends. 2013;7(5):209\u201320. doi: 10.5582\/bst.2013.v7.5.209 .","journal-title":"Biosci Trends"},{"issue":"8","key":"185_CR52","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00018-012-1115-1","volume":"70","author":"WJ Polacheck","year":"2013","unstructured":"Polacheck WJ, Zervantonakis IK, Kamm RD. Tumor cell migration in complex microenvironments. Cell Mol Life Sci. 2013;70(8):1335\u201356. doi: 10.1007\/s00018-012-1115-1 .","journal-title":"Cell Mol Life Sci"},{"key":"185_CR53","doi-asserted-by":"publisher","DOI":"10.3791\/4159","author":"AM Tchafa","year":"2012","unstructured":"Tchafa AM, Shah AD, Wang S, Duong MT, Shieh AC. Three-dimensional cell culture model for measuring the effects of interstitial fluid flow on tumor cell invasion. J Vis Exp. 2012;. doi: 10.3791\/4159 .","journal-title":"J Vis Exp."},{"issue":"4","key":"185_CR54","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2007.08.006","volume":"130","author":"KM Yamada","year":"2007","unstructured":"Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell. 2007;130(4):601\u201310. doi: 10.1016\/j.cell.2007.08.006 .","journal-title":"Cell"},{"issue":"3","key":"185_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrm1858","volume":"7","author":"LG Griffith","year":"2006","unstructured":"Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006;7(3):211\u201324. doi: 10.1038\/nrm1858 .","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"185_CR56","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/smll.200801788","volume":"5","author":"J Lee","year":"2009","unstructured":"Lee J, Lilly GD, Doty RC, Podsiadlo P, Kotov NA. In vitro toxicity testing of nanoparticles in 3D cell culture. Small. 2009;5(10):1213\u201321. doi: 10.1002\/smll.200801788 .","journal-title":"Small"},{"issue":"3","key":"185_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12079-011-0132-4","volume":"5","author":"A Nyga","year":"2011","unstructured":"Nyga A, Cheema U, Loizidou M. 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal. 2011;5(3):239\u201348. doi: 10.1007\/s12079-011-0132-4 .","journal-title":"J Cell Commun Signal"},{"issue":"2\u20133","key":"185_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1040-8428(00)00078-0","volume":"36","author":"MT Santini","year":"2000","unstructured":"Santini MT, Rainaldi G, Indovina PL. Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol. 2000;36(2\u20133):75\u201387.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Pt 6","key":"185_CR59","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1242\/jcs.108.6.2369","volume":"108","author":"WG Roberts","year":"1995","unstructured":"Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108(Pt 6):2369\u201379.","journal-title":"J Cell Sci"},{"issue":"24 Pt 1","key":"185_CR60","doi-asserted-by":"publisher","first-page":"8782","DOI":"10.1158\/1078-0432.CCR-05-1664","volume":"11","author":"AJ Primeau","year":"2005","unstructured":"Primeau AJ, Rendon A, Hedley D, Lilge L, Tannock IF. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res. 2005;11(24 Pt 1):8782\u20138. doi: 10.1158\/1078-0432.CCR-05-1664 .","journal-title":"Clin Cancer Res"},{"issue":"4","key":"185_CR61","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-08-3836","volume":"69","author":"WN Hait","year":"2009","unstructured":"Hait WN, Hambley TW. Targeted cancer therapeutics. Cancer Res. 2009;69(4):1263\u20137. doi: 10.1158\/0008-5472.CAN-08-3836 (discussion 7).","journal-title":"Cancer Res"},{"issue":"5","key":"185_CR62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2217\/cns.13.37","volume":"2","author":"KE Warren","year":"2013","unstructured":"Warren KE. Novel therapeutic delivery approaches in development for pediatric gliomas. CNS Oncol. 2013;2(5):427\u201335. doi: 10.2217\/cns.13.37 .","journal-title":"CNS Oncol"},{"issue":"1","key":"185_CR63","first-page":"3602","volume":"8","author":"CG England","year":"2013","unstructured":"England CG, Priest T, Zhang G, Sun X, Patel DN, McNally LR, et al. Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles. Int J Nanomed. 2013;8(1):3602\u201317.","journal-title":"Int J Nanomed"},{"issue":"6","key":"185_CR64","doi-asserted-by":"publisher","first-page":"e0129172","DOI":"10.1371\/journal.pone.0129172","volume":"10","author":"CG England","year":"2015","unstructured":"England CG, Huang JS, James KT, Zhang G, Gobin AM, Frieboes HB. Detection of Phosphatidylcholine- Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging. PLoS ONE. 2015;10(6):e0129172. doi: 10.1371\/journal.pone.0129172 .","journal-title":"PLoS ONE"},{"key":"185_CR65","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejpb.2015.02.017","volume":"92","author":"CG England","year":"2015","unstructured":"England CG, Miller MC, Kuttan A, Trent JO, Frieboes HB. Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles. Eur J Pharm Biopharm. 2015;92:120\u20139. doi: 10.1016\/j.ejpb.2015.02.017 .","journal-title":"Eur J Pharm Biopharm"},{"key":"185_CR66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-0-387-25842-3_15","volume-title":"BioMEMS and biomedical nanotechnology: volume I biological and biomedical nanotechnology","author":"HB Frieboes","year":"2006","unstructured":"Frieboes HB, Sinek JP, Nalcioglu O, Fruehauf JP, Cristini V. Nanotechnology in cancer drug therapy: a biocomputational approach. In: Ferrari M, Lee AP, Lee LJ, editors. BioMEMS and biomedical nanotechnology: volume I biological and biomedical nanotechnology. Boston: Springer Science + Business Media, LLC; 2006. p. 435\u201360."},{"issue":"6","key":"185_CR67","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s13346-013-0162-y","volume":"3","author":"M Li","year":"2013","unstructured":"Li M, Czyszczon EA, Reineke JJ. Delineating intracellular pharmacokinetics of paclitaxel delivered by PLGA nanoparticles. Drug Deliv Transl Res. 2013;3(6):551\u201361. doi: 10.1007\/s13346-013-0162-y .","journal-title":"Drug Deliv Transl Res"},{"key":"185_CR68","doi-asserted-by":"publisher","first-page":"55004","DOI":"10.1088\/1367-2630\/15\/5\/055004","volume":"15","author":"AL van de Ven","year":"2013","unstructured":"van de Ven AL, Abdollahi B, Martinez CJ, Burey LA, Landis MD, Chang JC, et al. Modeling of nanotherapeutics delivery based on tumor perfusion. New J Phys. 2013;15:55004. doi: 10.1088\/1367-2630\/15\/5\/055004 .","journal-title":"New J Phys"},{"issue":"1","key":"185_CR69","doi-asserted-by":"publisher","first-page":"11208","DOI":"10.1063\/1.3699060","volume":"2","author":"AL van de Ven","year":"2012","unstructured":"van de Ven AL, Wu M, Lowengrub J, McDougall SR, Chaplain MA, Cristini V, et al. Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors. AIP Adv. 2012;2(1):11208. doi: 10.1063\/1.3699060 .","journal-title":"AIP Adv"},{"issue":"28","key":"185_CR70","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1016\/j.biomaterials.2005.02.025","volume":"26","author":"TM Fahmy","year":"2005","unstructured":"Fahmy TM, Samstein RM, Harness CC, Mark Saltzman W. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials. 2005;26(28):5727\u201336. doi: 10.1016\/j.biomaterials.2005.02.025 .","journal-title":"Biomaterials"},{"issue":"1","key":"185_CR71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1158\/1535-7163.MCT-13-0502","volume":"13","author":"DT Martin","year":"2014","unstructured":"Martin DT, Steinbach JM, Liu J, Shimizu S, Kaimakliotis HZ, Wheeler MA, et al. Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer. Mol Cancer Ther. 2014;13(1):71\u201381. doi: 10.1158\/1535-7163.MCT-13-0502 .","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"185_CR72","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nmat2444","volume":"8","author":"KA Woodrow","year":"2009","unstructured":"Woodrow KA, Cu Y, Booth CJ, Saucier-Sawyer JK, Wood MJ, Saltzman WM. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater. 2009;8(6):526\u201333. doi: 10.1038\/nmat2444 .","journal-title":"Nat Mater"},{"issue":"2","key":"185_CR73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.036","volume":"156","author":"Y Cu","year":"2011","unstructured":"Cu Y, Booth CJ, Saltzman WM. In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery. J Control Release. 2011;156(2):258\u201364. doi: 10.1016\/j.jconrel.2011.06.036 .","journal-title":"J Control Release"},{"issue":"21","key":"185_CR74","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1016\/j.biomaterials.2011.03.031","volume":"32","author":"J Li","year":"2011","unstructured":"Li J, Feng L, Fan L, Zha Y, Guo L, Zhang Q, et al. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials. 2011;32(21):4943\u201350. doi: 10.1016\/j.biomaterials.2011.03.031 .","journal-title":"Biomaterials"},{"issue":"11","key":"185_CR75","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1023\/A:1012126301290","volume":"14","author":"MP Desai","year":"1997","unstructured":"Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1997;14(11):1568\u201373.","journal-title":"Pharm Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-016-0185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-016-0185-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-016-0185-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-016-0185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T10:20:50Z","timestamp":1655547650000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-016-0185-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s12951-016-0185-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]},"assertion":[{"value":"28 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}